Analogic (ALOG) Receives Media Impact Rating of 0.21

Share on StockTwits

Media coverage about Analogic (NASDAQ:ALOG) has trended somewhat positive recently, according to Accern. The research group scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Analogic earned a coverage optimism score of 0.21 on Accern’s scale. Accern also assigned press coverage about the medical research company an impact score of 44.7531616587051 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

These are some of the media headlines that may have impacted Accern’s scoring:

Analogic remained flat at $$83.95 on Monday, according to Marketbeat.com. 212,601 shares of the company traded hands, compared to its average volume of 216,896. The stock has a market cap of $1.05 billion, a price-to-earnings ratio of 48.81, a PEG ratio of 2.84 and a beta of 0.64. Analogic has a 12 month low of $67.85 and a 12 month high of $101.80.

Analogic (NASDAQ:ALOG) last posted its earnings results on Monday, June 4th. The medical research company reported $1.08 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.11. The firm had revenue of $119.97 million for the quarter, compared to analyst estimates of $113.60 million. Analogic had a positive return on equity of 6.77% and a negative net margin of 1.13%. sell-side analysts anticipate that Analogic will post 4.23 EPS for the current fiscal year.

ALOG has been the subject of several recent research reports. TheStreet lowered shares of Analogic from a “b-” rating to a “c” rating in a report on Monday, May 14th. BidaskClub lowered shares of Analogic from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 19th. ValuEngine lowered shares of Analogic from a “buy” rating to a “hold” rating in a report on Thursday, April 12th. Finally, Zacks Investment Research raised shares of Analogic from a “hold” rating to a “strong-buy” rating and set a $108.00 price target for the company in a report on Thursday, March 8th. Three investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $94.00.

Analogic Company Profile

Analogic Corporation designs, manufactures, and sells medical imaging systems, ultrasound and security systems, and subsystems to original equipment manufacturers (OEMs) and end users primarily for the medical and airport security markets worldwide. It operates in three segments: Medical Imaging, Ultrasound, and Security and Detection.

Insider Buying and Selling by Quarter for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.